Is the product quality inspected?

Yes, 100% inspection including visual and function checks is performed on finished products.

What certifications does the company hold?

The company holds ISO9001:2015 management system certification.

Can raw materials be traced?

Yes, full traceability is maintained for all raw materials.

380ml PC Buffer for Roche Procell M Chemiluminescence Immunoassay Reagent

Name: 380ml PC Buffer for Roche Procell M Chemiluminescence Immunoassay Reagent
Brand: Zhejiang Xinke Medical Technology Co., Ltd.
SKU: 2217204845

Zhejiang, ChinaZhejiang Xinke Medical Technology Co., Ltd.

US$1.30

1-499 Pieces

US$1.20

500-2,999 Pieces

US$1.00

3,000+ Pieces

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Reagent

Transport Package

Botte

Specification

Trademark

Xinke

Origin

China

HS Code

382219009

Production Capacity

500000 Pieces

Key features

Broad Compatibility: Suitable for Roche Cobas c702, c701, c502, c501, and c311 analyzers.

OEM Service Available: Flexible customization options provided for specific requirements.

Strict Quality Control: 100% visual and function inspection for all finished products.

Fast Lead Time: Within 15 workdays for both peak and off-peak seasons.

ISO9001 Certified: Management system certified to ISO9001:2015 standards.

Traceable Materials: Full traceability ensured for all raw materials used.

Experienced Manufacturer: Established in 2004 with 20 years of export experience.

Low MOQ: Minimum Order Quantity is just 1 piece.

Company profile

Importers and ExportersYears of Export Experience

Zhejiang Xinke Medical Technology Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: OEM Service Available CertifiedCustomization Options: Flexible customization CertifiedExport Year: 20 Years CertifiedNearest Port: Ningbo PortAverage Response Time: ≤2.79h

AI-Powered supplier vetting

SummaryThe supplier operates in the clinical in vitro diagnostic reagent field and reports ten years of ISO9001 and ISO13485 quality-system certification. It offers flexible customization, has OEM experience with well-known brands, possesses self-managed import/export rights, and has exported for 20 years, with exports representing 51%–70% of total sales. Quality inspection procedures are documented and consistently followed, while stated lead times are within 15 working days in both peak and off-season. However, the supplier reports no inventory, overseas warehouse, overseas showroom, overseas agents or branches, offline trade-show participation, ODM service, SDK, recent new-product development, ERP, OA, CRM, SAP, or broader digitalization initiatives. Financial information is inconsistent or insufficiently interpretable in the provided records, so financial credibility cannot be determined.

Supplier typeThe supplier identifies itself as a company in the clinical in vitro diagnostic reagent field and has self-managed import/export rights with 20 years of export experience. This supports classification as an export-capable manufacturer or supplier in the medical in vitro diagnostics sector.

CertificationsThe company states that it has maintained ISO9001 and ISO13485 quality-system certifications for ten years. These explicitly documented certifications support a positive assessment of its quality-system credentials.

R&D capabilityThe supplier reports no new products in the past year, no ODM service, no available SDK, and no current enterprise digitalization or technical-transformation plan. These explicit limitations indicate weak demonstrated innovation capability.

Customization capabilityThe supplier explicitly provides flexible customization through both its R&D and design-service capabilities. This directly supports a positive assessment of customization capability, although ODM service is not offered.

Client casesThe supplier states that it provides OEM services for well-known brands, which is evidence of relevant customer experience. No specific brand names, project details, or verifiable case descriptions are provided, so the evidence is positive but limited.